drugset / Trial / NCT01959412
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine the efficacy of indacaterol 55µg once daily (and 27.5 µg twice) in QVA149 compared to 75 µg indacaterol monotherapy.
Timeline
- Start
- 2013-11
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indacaterol | Other / unclassified | 27.5 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 37.5 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 55 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 75 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 150 ug | Inhaled |